5 Results for "

portal hypertensive

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "portal hypertensive" in MCE Product Catalog:

Cat. No.: HY-108842
CAS No.: 215647-85-1
Synonyms: PegIFN a-2b; Sch 54031; Sylatron; ViraferonPeg

Target:  

HIV HCV

Research Areas:  

Infection Cancer

Peginterferon alfa-2b (PegIFN a-2b; Sch 54031; Sylatron; ViraferonPeg) is an immunomodulator. Peginterferon alfa-2b is a recombinant alfa-2b interferon covalently linked PEG with antiviral activity against HCV. Peginterferon alfa-2b decreases viral DNA in HIV. Peginterferon alfa-2b can be used in research of melanoma and hepatitis C .
loading...
    loading...
Cat. No.: HY-U00013R
CAS No.: 158836-71-6
Synonyms: HCT 1206 (Standard); NO-flurbiprofen (Standard); Nitroxybutyl flurbiprofen (Standard)
Target:  

Reference Standards COX

Research Areas:  

Cardiovascular Disease

Nitroflurbiprofen is a cyclooxygenase (COX) inhibitor with nitric oxide (NO)-donating properties, modulates the increased intrahepatic vascular tone in portal hypertensive cirrhotic rats.
loading...
    loading...
Cat. No.: HY-111291
CAS No.: 85273-95-6
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease Endocrinology

ICI 169369 (free base) is an orally active, selective and non-competitive antagonist against 5HT receptor. ICI 169369 (free base) blunts the vasopressin (AVP), but not the ACTH, prolactin or growth hormone reponses to insulin-induced hypoglycaemia. ICI 169369 (free base) blocks centrally mediated 5-HT responses and lowers portal pressure in portal hypertensive rats .
loading...
    loading...
Cat. No.: HY-U00013
CAS No.: 158836-71-6
Synonyms: HCT 1206; NO-flurbiprofen; Nitroxybutyl flurbiprofen
Target:  

COX

Research Areas:  

Cardiovascular Disease

Nitroflurbiprofen is a cyclooxygenase (COX) inhibitor with nitric oxide (NO)-donating properties, modulates the increased intrahepatic vascular tone in portal hypertensive cirrhotic rats.
loading...
    loading...
Cat. No.: HY-183206
CAS No.: 149455-36-7
UR 8225 is an orally active ATP-sensitive K + channel activator with vasodilator, smooth muscle relaxant, antihypertensive, and bronchodilator activities. UR 8225 induces membrane hyperpolarization by increasing outward K + conductance and reduces Ca 2+ influx through voltage-gated L-type Ca 2+ channels. UR 8225 reduces total peripheral vascular resistance, shortens cardiac action potential duration, inhibits agonist-induced Ca 2+ influx, and stimulates renin release. UR 8225 induces reflex tachycardia but lacks β-adrenergic receptor blocking activity. UR 8225 is widely applicable to research in fields related to hypertension, myocardial ischemia, ventricular fibrillation, and other conditions .
loading...
    loading...